The Circadian Rhythm Disorders market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Circadian Rhythm Disorders: An Overview
The circadian rhythm is crucial to different physiological processes. In addition to sleep, this rhythm helps regulate body temperature, eating and digestion, and hormonal activity. The master circadian clock is found in the hypothalamus of the brain and is composed of a cluster of proteins known as the suprachiasmatic nucleus (SCN). In a healthy adult, this clock resets – or “entrains” – every 24 h based on light and darkness cycles. A healthy person who wakes up in the morning will gradually become more tired throughout the day, and feelings of sleepiness will peak in the evening when it is dark out.
Circadian Rhythm Disorders Market Key Facts
-
A study by Yamadera et al. (n.d.), titled “A multicenter study of sleep-wake rhythm disorders: Clinical features of sleep-wake rhythm disorders,” reported 90 cases (74%) of DSPS and 13 cases (11%) of non-24 among 121 cases of circadian rhythm sleep disorders (CRSDs).
-
As per the review by Zhu et al. (2013), titled “Circadian Rhythm Sleep Disorders (CRSD),” delayed sleep phase disorder (DSPD) is the most common CRSD with an estimated prevalence of 0.17% in the general population and 7–16% among adolescents. It has been estimated that 5–10% of chronic insomnia patients in sleep clinics have DSPD.
-
According to Kim et al., an estimated 10% of adult and 16% of adolescent sleep disorders patients may have circadian rhythm disorder (CRD)
Get FREE sample copy at: Circadian Rhythm Disorders Therapeutics Market
Key Benefits of Circadian Rhythm Disorders Market Report
-
The report provides an in-depth analysis of Circadian Rhythm Disorders Market Size and Share till 2030 in the seven major markets.
-
The report will help in developing business strategies by understanding the Circadian Rhythm Disorders Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.
-
It covers Circadian Rhythm Disorders current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.
-
The report provides a detailed assessment of the Circadian Rhythm Disorders market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.
Circadian Rhythm Disorders Market
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Circadian Rhythm Disorders market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Circadian Rhythm Disorders market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Circadian Rhythm Disorders Epidemiology
The epidemiology section covers insights about the historical and current Circadian Rhythm Disorders patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Circadian Rhythm Disorders Epidemiology Segmentation
-
Total Prevalence of Circadian Rhythm Disorders
-
Type-specific Prevalence of Circadian Rhythm Disorders
-
Diagnosed and Treatable Cases of Circadian Rhythm Disorders
Circadian Rhythm Disorders Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Circadian Rhythm Disorders market or expected to get launched in the market during the study period. The analysis covers Circadian Rhythm Disorders market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Circadian Rhythm Disorders Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Circadian Rhythm Disorders Therapeutics Analysis
The current emerging pipeline of Circadian Rhythm Disorders (CRDs) is weak, with only a few key players investing. Nevertheless, the various subtypes offer a great opportunity for the development of novel therapies.
Currently, Vanda Pharmaceuticals is working on VEC-162 (HETLIOZ) for the treatment of Circadian Rhythm Disorders. VEC-162 (HETLIOZ) is a melatonin receptor agonist indicated for the treatment of N24HSWD.
Request for Sample @ Circadian Rhythm Disorders Emerging Therapies and Key Companies
Table of Content
1. Key Insights
2. Executive Summary
3. Circadian Rhythm Disorders Competitive Intelligence Analysis
4. Circadian Rhythm Disorders Market Overview at a Glance
5. Circadian Rhythm Disorders Disease Background and Overview
6. Circadian Rhythm Disorders Patient Journey
7. Circadian Rhythm Disorders Epidemiology and Patient Population
8. Circadian Rhythm Disorders Treatment Algorithm, Current Treatment, and Medical Practices
9. Circadian Rhythm Disorders Unmet Needs
10. Key Endpoints of Circadian Rhythm Disorders Treatment
11. Circadian Rhythm Disorders Marketed Products
12. Circadian Rhythm Disorders Emerging Therapies
13. Circadian Rhythm Disorders Seven Major Market Analysis
14. Attribute Analysis
15. Circadian Rhythm Disorders Market Outlook (7 major markets)
16. Circadian Rhythm Disorders Access and Reimbursement Overview
17. KOL Views on the Circadian Rhythm Disorders Market.
18. Circadian Rhythm Disorders Market Drivers
19. Circadian Rhythm Disorders Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/circadian-rhythm-disorders-market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/